PREVENTION OF DIABETES MELLITUS TYPE 2
Keywords:
Prevention, obesity, prediabetes, diabetes mellitus.Abstract
The current global epidemic of diabetes mellitus type 2 (T2DM) is primarily a consequence of overweight/ obesity and a sedentary lifestyle. The prevention or modification of progressive insulin resistance is the key to preventing the development of diabetes. Along with lifestyle modification, pharmacological treatment methods (metformin, weight loss drugs – sibutramine) reduce the risk of progression of prediabetes in T2DM.
References
Popkin B.M., Adair L.S., Ng S.W. Global nutrition transition and the pandemic of obesity in developing countries // Nutr. Rev. 2012. Vol. 70, N 1. P. 3–21.
WHO obesity and overweight fact sheet, update in October 2017. URL: http://www.who.int/mediacentre/factsheets/fs311/ru/
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. URL: www.diabetesatlas.org. (date of access December 31, 2015)
Gerstein H.C., Santaguida P., Raina P., Morrison K.M. et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies // Diabetes Res. Clin. Pract. 2007. Vol. 78, N 3. P. 305– 312.
World Health Organization Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva : World Health Organization, 2009.
Nolan C.J., Ruderman N.B., Prentki M. Intensive insulin for type 2 diabetes: the risk of causing harm // Lancet Diabetes Endocrinol. 2013. Vol. 1. P. 9–10.
Mehran A.E., Templeman N.M., Brigidi G.S., Lim G.E. et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production // Cell Metab. 2012. Vol. 16. P. 723–737.
Melloul D., Marshak S., Cerasi E. Regulation of insulin gene transcription // Diabetologia. 2002. Vol. 45. P. 309–326.
Hay C.W., Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research // Diabetes. 2006. Vol. 55. P. 3201–3213.
Lim G.E., Albrecht T., Piske M., Sarai K. et al. Zeta coordinates adipogenesis of visceral fat // Nat. Commun. 2015. Vol. 6. P. 7671.
Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes // J. Clin. Invest. 2006. Vol. 116. P. 1802–1812.
Meur G., Qian Q., da Silva Xavier G., Pullen T.J. et al. Nucleocytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6) // J. Biol. Chem. 2011. Vol. 286. P. 13 647–13 656.
Templeman N.M., Skovso S., Page M.M., Lim G.E. et al. A causal role for hyperinsulinemia in obesity // J. Endocrinol. 2017. Vol. 232. P. R173–R183.
Pan X.R., Li G.W., Hu Y.H. et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study // Diabetes Care. 1997. Vol. 20. P. 537–544.
Tuomilehto J., Lindstrom J., Eriksson J.G. et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance // N. Engl. J. Med. 2001. Vol. 344. P. 1343–1350.
Azerbaijan
Türkiye
Uzbekistan
Kazakhstan
Turkmenistan
Kyrgyzstan
Republic of Korea
Japan
India
United States of America
Kosovo